Bicalutamide 50 mg

DRUG4 trials

Sponsors

Marco Lorenzo Bonu, Radboud University Medical Center, Royal College of Surgeons, Ireland, University of California, San Francisco

Conditions

Androgen ExcessMetabolic DiseaseNAFLDPCOSPolycystic Ovary SyndromeProstate CancerSalivary Duct Carcinoma

Phase 1

Bicalutamide Therapy in Young Women With NAFLD and PCOS

RecruitingNCT05979389

University of California, San FranciscoNAFLD, PCOS

Start: 2024-02-14End: 2028-08-31Target: 50Updated: 2025-05-08

Phase 2

Phase II Dutasteride in Combination With CAB vs CAB in SDC

RecruitingNCT05513365

Radboud University Medical CenterSalivary Duct Carcinoma

Start: 2022-09-27End: 2027-09-30Target: 26Updated: 2025-06-04

Phase 3

SRT Versus SRT+ADT in Prostate Cancer

RecruitingNCT05019846

Marco Lorenzo BonuProstate Cancer

Start: 2021-09-30End: 2029-12-01Target: 310Updated: 2023-04-18

Unknown Phase

The RolE oF Androgen Excess in MUscle Energy MetaboLism in Women With PolyCystic Ovary Syndrome (REFUEL PCOS) Study 2

Royal College of Surgeons, IrelandAndrogen Excess, Metabolic Disease, Polycystic Ovary Syndrome

Start: 2023-01-01End: 2025-09-01Target: 16Updated: 2022-12-12

Related Papers

A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.

2024-09-204 citations